Pharmacoeconomics of Genetically Engineered Drugs

@article{JonesGrizzle1992PharmacoeconomicsOG,
  title={Pharmacoeconomics of Genetically Engineered Drugs},
  author={Amy J. Jones-Grizzle and Dr J. Lyle Bootman},
  journal={PharmacoEconomics},
  year={1992},
  volume={1},
  pages={45-53}
}
Biotechnology is a rapidly developing area of drug development which has great growth potential. Development of genetically engineered drugs is very expensive and as these products become available the impact on healthcare costs could be vast. The cost-benefit ratio of biotechnology products needs to be established, but few relevant pharmacoeconomic studies… CONTINUE READING